Finepoint Capital LP
Follow13F filer, CIK 1608126, BOSTON, MA
Finepoint Capital LP reported $2,798,914,992 across 9 holdings for the quarter ended 2026-06-30, in a 13F-HR filed 2026-08-13.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000904454-26-000450
- Period
- 2026-06-30
- Reported value
- $2.8B
- Holdings
- 9
- Top 10 weight
- 100%
- New
- 1
- Sold out
- 1
Largest buys vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| QXOadded | +4,255,435 | $73.5M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Largest sells vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| RXOreduced | -4,718,173 | -$130M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Holdings, Q2 2026
Share positions as resolved from 13F-HR 0000904454-26-000450, largest first. % of portfolio is the value over $461,028,576, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| QXOQXO INC | 18,113,850 | $313M | 67.89% | +4,255,435 | Timeline | ||
| RXORXO INC | 5,355,445 | $148M | 32.05% | -4,718,173 | Timeline | ||
| ANNAWALEANNA INC | 490,000 | $147K | 0.03% | 0 | Timeline | ||
| ANNAALEANNA INC | 27,717 | $80.4K | 0.02% | 0 | Timeline | ||
| MNYWWMONEYHERO LIMITED | 895,000 | $37K | 0.01% | 0 | Timeline | ||
| CLDICALIDI BIOTHERAPEUTICS INC | 1,042 | $177 | <0.01% | 0 | Timeline |
Options
Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).
Sold out in Q2 2026
Positions in the previous quarter's report that this quarter's report no longer lists.
| Security | Shares before | Value before | Type |
|---|---|---|---|
| SOXXISHARES TR | 1,469,968 | $483M | put |
How Q2 2026 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0000904454-26-000450 | base | 2026-08-13 | acceptance time not in the bulk data set |